Baird Medical Accelerates U.S. Expansion at NASOIE 2026

Baird Medical Accelerates U.S. Expansion at NASOIE 2026 [Accessibility Statement] Skip NavigationNEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami, Florida. Building on successful engagements at previous NASOIE gathering ...